Passage Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.About PASG
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.
CEOWilliam Chou
CEOWilliam Chou
Employees60
Employees60
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees60
Employees60
PASG Key Statistics
Market cap30.89M
Market cap30.89M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume51.27K
Average volume51.27K
High today$10.29
High today$10.29
Low today$9.66
Low today$9.66
Open price$9.95
Open price$9.95
Volume82.33K
Volume82.33K
52 Week high$20.20
52 Week high$20.20
52 Week low$5.12
52 Week low$5.12
Stock Snapshot
The current Passage Bio(PASG) stock price is $10.05, with a market capitalization of 30.89M. The stock trades at a price-to-earnings (P/E) ratio of -0.68.
As of 2025-12-15, Passage Bio(PASG) stock has fluctuated between $9.66 and $10.29. The current price stands at $10.05, placing the stock +4.0% above today's low and -2.3% off the high.
Passage Bio(PASG) shares are trading with a volume of 82.33K, against a daily average of 51.27K.
During the past year, Passage Bio(PASG) stock moved between $5.12 at its lowest and $20.20 at its peak.
During the past year, Passage Bio(PASG) stock moved between $5.12 at its lowest and $20.20 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PASG. This list is generated using Robinhood data, and it’s not a recommendation.